Searchable abstracts of presentations at key conferences in endocrinology

ea0081p149 | Pituitary and Neuroendocrinology | ECE2022

Clinical aspects of pituitary tumors in patients with Multiple Endocrine Neoplasia Type 1: results from the preliminary study

Zgliczynski Stanislaw , Kochman Magdalena , Zgliczynski Wojciech , Bednarczuk Tomasz

Introduction: Multiple Endocrine Neoplasia Type 1 (MEN1) is a rare disease inherited in an autosomal dominant pattern, caused by mutations in the MEN1 gene. The cardinal components of this syndrome are: primary hyperparathyroidism (PHPT), gastroenteropancreatic neuroendocrine tumors (NETs) and pituitary tumors.Aim: The aim of the study was to evaluate clinical features of MEN1 patients under care of two teritiary centers in Warsaw, Poland with special fo...

ea0049gp173 | Pituitary | ECE2017

A comparison of single-dose effects of short acting somatostatin analogs: octreotide vs pasireotide in patients with active acromegaly after surgical debulking

Majos Agnieszka , Stelmachowska-Banas Maria , Czajka-Oraniec Izabella , Zgliczynski Wojciech

Acromegaly is a rare endocrine disorder caused by growth hormone (GH) secreting pituitary adenoma. The treatment of choice is transsphenoidal surgery. In patients with persistent disease after surgery medical therapy is recommended. First-line medical treatment include first generation long-acting somatostatin analogs: octreotide LAR and lanreotide autogel. Recently, pasireotide – a second generation somatostatin analog has been investigated in patients with acromegaly.</...

ea0035p176 | Cardiovascular Endocrinology &amp; Lipid Metabolism | ECE2014

Serum and plasma aldosterone levels and the respective aldosterone/plasma renin indices in healthy blood donors

Glinicki Piotr , Jeske Wojciech , Kapuscinska Renata , Zgliczynski Wojciech

Introduction: Primary aldosteronism (PA) is one of the causes of hypertension. Blood aldosterone and the aldosterone/direct renin concentration (DRC) are routinely used as a screening test for PA.Aim of study: Whether it matters if aldosterone concentration is determined in serum or plasma samples?Material and methods: 145 healthy males, five females (blood donors) were investigated. In all subjects blood was collected into two tub...

ea0035p479 | Diabetes therapy | ECE2014

Gastric contractility modulation: a novel method for the treatment of type 2 diabetes mellitus with overweight and obesity: a preliminary results of the clinical study

Kozakowski Jaroslaw , Lebovitz Harold E , Tarnowski Wieslaw , Zgliczynski Wojciech

Introduction: We present preliminary results of the treatment with DIAMOND system – novel method of therapy of type 2 diabetes (T2DM) associated with obesity, based on new technology – gastric contractility modulation (GCM).Material and methods: In 23 overweight/obese patients with T2DM enrolled into the polish arm of the multicenter, prospective, randomized study device modulating gastric contractility was implanted. We present data from nine ...

ea0035p532 | Endocrine tumours and neoplasia | ECE2014

Comparison of chromogranin A levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males

Glinicki Piotr , Jeske Wojciech , Kapuscinska Renata , Zgliczynski Wojciech

Introduction: Chromogranin A (CgA) is a main, nonspecific marker of neuroendocrine tumours (NET). There are various commercially assays for the measurement of CgA concentration in serum or plasma. These assays differ in analytical techniques (RIA, ELISA, CLIA), have different standardization, and use different antibodies which recognize different epitopes of CgA molecule.Aim of study: Our study was designed to confirm the noted earlier differences in CgA...

ea0035p927 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Histiocytosis of pituitary gland: a case report

Jankowska Katarzyna , Baranowska-Bik Agnieszka , Bardadin Jan , Zgliczynski Wojciech

Histiocytosis is a disease caused by growth of histiocytes within one or more organs. Symptomatology may be very different: from isolated skin or bone lesions, by diabetes insipidus after life-threatening multisystem form. Diabetes insipidus as a symptom of pituitary can be observed many years before visibility of the changes in magnetic resonance imaging.A case of 59-year-old woman who has experienced diabetes insipidus with no other symptoms of hypopit...

ea0035p935 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Prevalence of thyroid dysfunction in naive acromegalic patients

Czajka-Oraniec Izabella , Stelmachowska-Banas Maria , Kochman Magdalena , Zgliczynski Wojciech

Introduction: Thyroid diseases are frequent in acromegalic patients. We aimed to investigate thyroid function and morphology in a population of patients with de novo acromegaly.Materials and methods: We evaluated 32 patients newly diagnosed with acromegaly in a single medical center. We collected data on patient’s age, sex, duration of acromegaly symptoms, history of thyroid disease, laboratory tests results (serum GH, IGF1, TSH, fT4, fT3, ...

ea0070aep606 | Pituitary and Neuroendocrinology | ECE2020

Clinical picture and MRI findings in patients with hypophysitis – a single-centre experience

Czajka-Oraniec Izabella , Stelmachowska-Banas Maria , Cylke Karolina , Zgliczynski Wojciech

Hypophysitis is a rare clinical condition manifesting as pituitary dysfunction: hypopituitarism or diabetes insipidus (DI) and pituitary enlargement causing mass effect (headaches, visual disturbances) due to the inflammation of the pituitary gland. We conducted a retrospective analysis of medical records of patients diagnosed with hypophysitis in the Department of Endocrinology of the Bielanski Hospital from 2014 to 2019. Twenty-five patients were identified, which represents...

ea0070aep634 | Pituitary and Neuroendocrinology | ECE2020

Unusual case of women suffering from aggressive silent thyrotropinoma treated with somatostatin analogues during pregnancy

Zgliczynska Magdalena , Majos Agnieszka , Stelmachowska-Banas Maria , Zgliczynski Wojciech

Background: Thyroid-stimulating hormone (TSH) expressing tumors are one of the rarest pituitary adenomas and comprises 0.5–2% of all cases. To our knowledge, only four cases of thyrotropinoma in a pregnant women have been reported up to date.Case presentation: We present a case of 24-year old women who reported to gynecologist due to secondary amenorrhea and severe headaches. Commissioned laboratory test showed, among others, prolactin 31.0 ng/ml a...

ea0070aep818 | Reproductive and Developmental Endocrinology | ECE2020

Epidemiology, clinical features and management of multiple endocrine neoplasia Type 1 – a two-center study

Zgliczynski Stanislaw , Bednarczuk Tomasz , Rogozik Natalia , Kochman Magdalena , Wojciech Zgliczynski

Background: Multiple Endocrine Neoplasia Type 1 (MEN1) is a rare, autosomal dominant disease characterized by the coexistence of at least two of the following: primary hyperparathyroidism (PHPT), neuroendocrine tumors (NET) and pituitary tumors. The aim of the study was to evaluate epidemiology, clinical features and management of MEN1 patients in two referral centers in Warsaw, Poland.Material and Methods: Study group consisted of 52 patients, aged from...